















National Medical Insurance Category A
It is an oral prodrug of the bactericidal cephalosporin antibiotic cefuroxime, exhibiting broad-spectrum activity against both Gram-positive and Gram-negative bacteria, with resistance to most beta-lactamases.
Primary Indications
This product is indicated for the treatment of the following infectious diseases caused by susceptible bacteria.
1. Acute tonsillitis, pharyngitis, and acute bacterial sinusitis;
2. Acute bacterial otitis media;
3. Acute exacerbations of chronic bronchitis;
4. Uncomplicated skin and soft tissue infections;
5. Uncomplicated urinary tract infections;
6. Treatment of early-stage Lyme disease (in adults and children aged 3 months and above);
7. Gonorrhoea, uncomplicated acute gonococcal urethritis and cervicitis.
Contraindicated in patients with a history of allergy to cephalosporin antibiotics.
Dosage Form
Tablet
Service Hotline:
Add:No. 66, Yong'an Road, High-tech Zone, Suzhou City, Jiangsu Province
Public Account
Service Number
Baijiahao
Copyright © 2025 Suzhou Chung-Hwa Chemical&Pharmaceutical Industrial Co.,Ltd. All Rights Reserved
Friendly Links: Chung-Hwa HoldingsSuzhou Chung-Hwa YuminChung-Hwa Lohas Health